Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Gene Expression × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Blood Specimen Collection 17 Cyclophosphamide 10 Photochemotherapy 9 fludarabine phosphate 8 Standard of Care 8 Peripheral Blood Stem Cell Transplantation 8 Educational Status 8 Cyclosporine 8 Radiotherapy 7 Radiosurgery 7 Early Intervention, Educational 7 Biopsy 7 Whole-Body Irradiation 6 Tomography, Optical Coherence 6 Surveys and Questionnaires 6 Surgical Procedures, Operative 6 Practice Guidelines as Topic 6 Mycophenolic Acid 6 Methods 6 Filgrastim 6 Aminolevulinic Acid 6 Psychiatric Rehabilitation 5 Melphalan 5 Therapeutics 4 Magnetic Resonance Spectroscopy 4 Fluorouracil 4 Dermoscopy 4 Curettage 4 Antilymphocyte Serum 4 pembrolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02236546 2017-04-13

FDG-PET in Advanced Melanoma

Vanderbilt-Ingram Cancer Center

Phase NA Terminated

3 enrolled 4 charts

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡